JUBILANT PHARMOVA LIMITED revenue for the last year amounted to 67.72 B INR, the most of which — 30.01 B INR — came from its highest performing source at the moment, Radiopharma, the year earlier bringing 25.52 B INR. The greatest contribution to the revenue figure was made by Americas and Europe — last year it brought JUBILANT PHARMOVA LIMITED 60.12 B INR, and the year before that — 55.93 B INR.